AJP - Heart Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 286: H1248-H1257, 2004; doi:10.1152/ajpheart.00599.2003
0363-6135/04 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (16)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zolk, O.
Right arrow Articles by Eschenhagen, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zolk, O.
Right arrow Articles by Eschenhagen, T.

Effects of chronic endothelin-1 stimulation on cardiac myocyte contractile function

Oliver Zolk,1,* Felix Münzel,1,* and Thomas Eschenhagen2

1Institut für Experimentelle und Klinische Pharmakologie und Toxikologie, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen; and 2Institut für Experimentelle und Klinische Pharmakologie, Universitätsklinikum Hamburg-Eppendorf, 20246 Hamburg, Germany

Submitted 25 June 2003 ; accepted in final form 31 October 2003

Endothelin-1 (ET-1) has acute positive inotropic effects, but consequences of chronically increased ET-1 on contractile function of cardiac myocytes are largely unknown. In the present study, effects of long-term treatment with ET-1 (10 nM) for 5 days on both force development [force of contraction (FOC)] and kinetics of contraction were determined in heart tissue reconstituted from rat cardiac cells. Isometric force was measured in response to cumulative concentrations of Ca2+ and isoprenaline. ET-1 augmented basal FOC by 64 ± 11% (P < 0.05), which was associated with a significantly blunted contractile response to Ca2+ and isoprenaline. Moreover, ET-1 significantly prolonged relaxation (62 ± 3 vs. 53 ± 2 ms). Selective ETA (BQ-123) and ETB receptor blockade (BQ-788) demonstrated that effects of ET-1 on contractile function were mediated through the ETA receptor subtype. Effects of ET-1 were prevented by cotreatment with either Ro31-8425, a PKC inhibitor, or dimethylamiloride, an inhibitor of the Na+/H+ exchanger. In contrast to long-term ET-1 treatment, no changes in contractile parameters were observed after ET-1 treatment for 3 h before force measurement. These data suggest that chronic ET-1 stimulation has dual effects on contractility: improvement of basal force but impairment of twitch kinetics and inotropic responsiveness to {beta}-adrenoceptor stimulation. The signaling pathways involved include ETA receptors, PKC, and the Na+/H+ exchanger. The present in vitro findings raise the possibility that ET-1 may exert both adaptive and maladaptive effects in the failing myocardium in which local accumulation of ET-1 is present.

engineered heart tissue; Na+/H+ exchanger



Address for reprint requests and other correspondence: O. Zolk, Institut für Experimentelle und Klinische Pharmakologie und Toxikologie, Friedrich-Alexander-Universität Erlangen-Nürnberg, Fahrstr. 17, 91054 Erlangen, Germany (E-mail: Zolk{at}pharmakologie.uni-erlangen.de).




This article has been cited by other articles:


Home page
CirculationHome page
I. Szokodi, R. Kerkela, A.-M. Kubin, B. Sarman, S. Pikkarainen, A. Konyi, I. G. Horvath, L. Papp, M. Toth, R. Skoumal, et al.
Functionally Opposing Roles of Extracellular Signal-Regulated Kinase 1/2 and p38 Mitogen-Activated Protein Kinase in the Regulation of Cardiac Contractility
Circulation, October 14, 2008; 118(16): 1651 - 1658.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. B. Murray, J. D. Gardner, G. L. Brower, and J. S. Janicki
Effects of nonselective endothelin-1 receptor antagonism on cardiac mast cell-mediated ventricular remodeling in rats
Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1251 - H1257.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Kruger, C. Sachse, W. H. Zimmermann, T. Eschenhagen, S. Klede, and W. A. Linke
Thyroid Hormone Regulates Developmental Titin Isoform Transitions via the Phosphatidylinositol-3-Kinase/ AKT Pathway
Circ. Res., February 29, 2008; 102(4): 439 - 447.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. P. Lourenco, R. Roncon-Albuquerque Jr., C. Bras-Silva, B. Faria, J. Wieland, T. Henriques-Coelho, J. Correia-Pinto, and A. F. Leite-Moreira
Myocardial dysfunction and neurohumoral activation without remodeling in left ventricle of monocrotaline-induced pulmonary hypertensive rats
Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1587 - H1594.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
A. Proven, H. L. Roderick, S. J. Conway, M. J. Berridge, J. K. Horton, S. J. Capper, and M. D. Bootman
Inositol 1,4,5-trisphosphate supports the arrhythmogenic action of endothelin-1 on ventricular cardiac myocytes
J. Cell Sci., August 15, 2006; 119(16): 3363 - 3375.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
F. Munzel, U. Muhlhauser, W.-H. Zimmermann, M. Didie, K. Schneiderbanger, P. Schubert, S. Engmann, T. Eschenhagen, and O. Zolk
Endothelin-1 and isoprenaline co-stimulation causes contractile failure which is partially reversed by MEK inhibition
Cardiovasc Res, December 1, 2005; 68(3): 464 - 474.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.